Latest & greatest articles for fatigue

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on fatigue or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on fatigue and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for fatigue

101. Biologic interventions for fatigue in rheumatoid arthritis. (PubMed)

Biologic interventions for fatigue in rheumatoid arthritis. Fatigue is a common and potentially distressing symptom for patients with rheumatoid arthritis (RA), with no accepted evidence-based management guidelines. Evidence suggests that biologic interventions improve symptoms and signs in RA as well as reducing joint damage.To evaluate the effect of biologic interventions on fatigue in rheumatoid arthritis.We searched the following electronic databases up to 1 April 2014: Cochrane Central (...) a biologic intervention in people with rheumatoid arthritis and had self reported fatigue as an outcome measure.Two reviewers selected relevant trials, assessed methodological quality and extracted data. Where appropriate, we pooled data in meta-analyses using a random-effects model.We identified 32 studies for inclusion in this current review. Twenty studies evaluated five anti-tumour necrosis factor (anti-TNF) biologic agents (adalimumab, certolizumab, etanercept, golimumab and infliximab), and 12

Full Text available with Trip Pro

2016 Cochrane

102. Evaluating the Impact of Whole-Body Vibration (WBV) on Fatigue and the Implications for Driver Safety (PubMed)

Evaluating the Impact of Whole-Body Vibration (WBV) on Fatigue and the Implications for Driver Safety Driver fatigue is a significant contributor to motor vehicle accidents and fatalities, although the exact share of those events attributable to fatigue is still uncertain. In 2013, accidents involving heavy trucks killed more than 3,944 people in the United States, with over 80 percent of those killed not in the truck. Numerous factors contribute to driver fatigue among commercial drivers (...) , including shiftwork schedules; high prevalence of alcohol and substance use; extended hours; comorbid medical conditions, such as pain; and high prevalence of sleep disorders. Many of these factors have been studied extensively in the trucking industry. Whole-body vibration (WBV) is another potential factor that may contribute to driver fatigue, but it has received little attention. Beginning in January 2015, Bose Corporation and AIG commissioned the RAND Corporation to study the link between WBV

Full Text available with Trip Pro

2016 Rand health quarterly

103. Interventions for the management of fatigue in adults with a primary brain tumour. (PubMed)

Interventions for the management of fatigue in adults with a primary brain tumour. Fatigue is a common and disabling symptom in people with a primary brain tumour (PBT). The effectiveness of interventions for treating clinically significant levels of fatigue in this population is unclear.To assess the effectiveness and safety of pharmacological and non-pharmacological interventions for adults with PBT and high levels of fatigue.In March 2016, we searched the Cochrane Register of Controlled (...) Trials (CENTRAL), MEDLINE, PsycINFO and CINAHL and checked the reference lists of included studies. We also searched relevant conference proceedings, searched for ongoing trials via ClinicalTrials.gov and contacted major co-operative groups with trials in this area.We included randomised controlled trials (RCTs) that investigated any pharmacological or non-pharmacological intervention in adults with PBT and fatigue, where fatigue was the primary outcome measure. We restricted inclusion specifically

Full Text available with Trip Pro

2016 Cochrane

104. Fatigue and Depression in Iranian Amyotrophic Lateral Sclerosis Patients in Tehran in 2012 (PubMed)

Fatigue and Depression in Iranian Amyotrophic Lateral Sclerosis Patients in Tehran in 2012 Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a progressive and rapid course. Fatigue and depression are common among ALS patients. The aim of this study was to determine the relationship between depression and fatigue in Iranian ALS patients.In this 2012 cross-sectional study, 40 ALS patients, including 22 females and 18 males, were selected through consecutive relapsing (...) -remitting, and 40 age- and gender-matched health controls (HCs) were recruited from Loghman Hakim Hospital in Tehran, Iran. The Persian version of the Fatigue Severity Scale (FSS-Per) questionnaire and depression substance of Hospital Anxiety and Depression Scale (HADS) were used to assess fatigue and depression. Data were analyzed using the Kolmogorov-Sminov Test, Levene's test, Independent Samples t-test, and Pearson product-moment correlation coefficient.We identified a significant and positive

Full Text available with Trip Pro

2016 Electronic physician

105. The Pathophysiology of Fatigue in Parkinson's Disease and its Pragmatic Management (PubMed)

The Pathophysiology of Fatigue in Parkinson's Disease and its Pragmatic Management Fatigue is 1 of the most common and most disabling symptoms among patients with Parkinson's disease (PD) and has a significant impact on their quality of life. Yet the pathophysiology of fatigue is poorly understood, while its treatment is "limited to an empirical approach based on plausible hypotheses."PubMed was searched for articles with the key words "Parkinson's disease" or "parkinsonism" and "fatigue (...) " that were published by or before August 2015. The analysis of articles, which were selected on subjective grounds, was used to review the current knowledge of pathophysiology and treatment outcomes in studies focused on fatigue in PD.Clinical and experimental findings support the view that fatigue is a primary manifestation of PD. The main hypothesized pathophysiological mechanisms include abnormal basal ganglia (BG)-cortical mechanisms, particularly frontal loops, and an imbalance between

Full Text available with Trip Pro

2016 Movement disorders clinical practice

106. Mortality of people with chronic fatigue syndrome: a retrospective cohort study in England and Wales from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Clinical Record Interactive Search (CRIS) Register. (PubMed)

Mortality of people with chronic fatigue syndrome: a retrospective cohort study in England and Wales from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Clinical Record Interactive Search (CRIS) Register. Mortality associated with chronic fatigue syndrome is uncertain. We investigated mortality in individuals diagnosed with chronic fatigue syndrome in secondary and tertiary care using data from the South London and Maudsley NHS Foundation Trust (...) Biomedical Research Centre (SLaM BRC) Clinical Record Interactive Search (CRIS) register.We calculated standardised mortality ratios (SMRs) for all-cause, suicide-specific, and cancer-specific mortality for a 7-year observation period using the number of deaths observed in SLaM records compared with age-specific and sex-specific mortality statistics for England and Wales. Study participants were included if they had had contact with the chronic fatigue service (referral, discharge, or case note entry

Full Text available with Trip Pro

2016 Lancet

107. Exercise therapy for chronic fatigue syndrome. (PubMed)

Exercise therapy for chronic fatigue syndrome. Chronic fatigue syndrome (CFS) is characterised by persistent, medically unexplained fatigue, as well as symptoms such as musculoskeletal pain, sleep disturbance, headaches and impaired concentration and short-term memory. CFS presents as a common, debilitating and serious health problem. Treatment may include physical interventions, such as exercise therapy, which was last reviewed in 2004.The objective of this review was to determine the effects (...) ), supportive listening (one study), pacing (one study), pharmacological treatment (one study) and combination treatment (one study). Risk of bias varied across studies, but within each study, little variation was found in the risk of bias across our primary and secondary outcome measures.Investigators compared exercise therapy with 'passive' control in eight trials, which enrolled 971 participants. Seven studies consistently showed a reduction in fatigue following exercise therapy at end of treatment, even

Full Text available with Trip Pro

2016 Cochrane

108. Fatigue in Parkinson’s disease: report from a mutidisciplinary symposium (PubMed)

Fatigue in Parkinson’s disease: report from a mutidisciplinary symposium Fatigue is a severe problem for many people living with Parkinson's disease (PD). Best estimates suggest that more than 50% of patients experience this debilitating symptom. Little is known about its etiology or treatment, making the understanding of fatigue a true unmet need. As part of the Parkinson's Disease Foundation Community Choice Research Program, patients, caregivers, and scientists attended a symposium (...) on fatigue on 16 and 17 October 2014. We present a summary of that meeting, reviewing what is known about the diagnosis and treatment of fatigue, its physiology, and what we might learn from multiple sclerosis (MS), depression, and cancer-disorders in which fatigue figures prominently too. We conclude with focused recommendations to enhance our understanding and treatment of this prominent problem in PD.

Full Text available with Trip Pro

2016 NPJ Parkinson's disease

109. Exercise for cancer fatigue

Exercise for cancer fatigue RACGP - Exercise for cancer fatigue Search Become a student member today for free and be part of the RACGP community A career in general practice Starting the GP journey Enrolments for the 2019.1 OSCE FRACGP exams closing 29 March 2019 Fellowship FRACGP exams Research Practice Experience Program is a self-directed education program designed to support non vocationally registered doctors on their pathway to RACGP Fellowship Fellowship International graduates FRACGP (...) Media Releases 2013 Media Releases 2012 Media Releases Search Exercise for cancer fatigue Exercise for cancer fatigue Introduction Cancer-related fatigue is a complex and common experience, affecting 70–100% of the cancer patient population. Intervention Aerobic exercise (walking, cycling) during and after cancer therapy. Indication Fatigue associated with cancer (specifically solid tumours) and its treatment. Cancer-related fatigue can have a profound physical, emotional, mental and social effect

2016 Handbook of Non-Drug interventions (HANDI)

110. Longitudinal study: Fatigue 2?months after myocardial infarction may indicate risk for persistent fatigue

Longitudinal study: Fatigue 2?months after myocardial infarction may indicate risk for persistent fatigue Fatigue 2 months after myocardial infarction may indicate risk for persistent fatigue | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Fatigue 2 months after myocardial infarction may indicate risk for persistent fatigue Article Text Adult nursing Longitudinal study Fatigue 2 months after myocardial infarction may indicate risk

2016 Evidence-Based Nursing

111. Avoiding alert fatigue in pulmonary embolism decision support: a new method to examine ?trigger rates?

Avoiding alert fatigue in pulmonary embolism decision support: a new method to examine ?trigger rates? Avoiding alert fatigue in pulmonary embolism decision support: a new method to examine ‘trigger rates’ | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Avoiding alert fatigue in pulmonary embolism decision support: a new method to examine ‘trigger rates’ Article Text Original EBM Research Avoiding alert fatigue in pulmonary embolism

2016 Evidence-Based Medicine (Requires free registration)

112. Stress (Fatigue/Insufficiency) Fracture, Including Sacrum, Excluding Other Vertebrae

Stress (Fatigue/Insufficiency) Fracture, Including Sacrum, Excluding Other Vertebrae American College of Radiology End User License Agreement ACR Appropriateness Criteria is a registered trademark of the American College of Radiology. By accessing the ACR Appropriateness Criteria®, you expressly agree and consent to the terms and conditions as described at: http://www.acr.org/~/media/ACR/Documents/AppCriteria/TermsandConditions.pdf Personal use of material is permitted for research, scientific (...) and/or information purposes only. You may not modify or create derivative works based on American College of Radiology material. No part of any material posted on the American College of Radiology Web site may be copied, downloaded, stored in a retrieval system, or redistributed for any other purpose without the expressed written permission of American College of Radiology. Revised 2016 ACR Appropriateness Criteria ® 1 Stress (Fatigue/Insufficiency) Fracture American College of Radiology ACR Appropriateness

2016 American College of Radiology

113. Fatigue in people with MS: can exercise help?

Fatigue in people with MS: can exercise help? Fatigue in people with MS: can exercise help? - Evidently Cochrane Search and hit Go By October 23, 2015 // I’ve just had an email from a Professor of Nursing, with a quote under her signature, which I haven’t seen before: “ There is nothing so useless as doing something efficiently which should not be done at all .” (Peter Drucker) In health research (as in life!) doing the right thing is critical. If research is to be useful, it’s really important (...) that it sets out to answer the right questions, those that matter to people affected by the condition being investigated. That’s the starting point for the work of the . I’ve written about one of their Priority Setting Partnerships, which bring together patients, health professionals and researchers to find the top priorities for research. The hope is that research funding will then be used to investigate the most important uncertainties. Reducing fatigue – a top priority in MS research People affected

2015 Evidently Cochrane

114. Interventions for fatigue in Parkinson's disease. (PubMed)

Interventions for fatigue in Parkinson's disease. Factors contributing to subjective fatigue in people with idiopathic Parkinson's disease (PD) are not well known. This makes it difficult to manage fatigue effectively in PD.To evaluate the effects of pharmacological and non-pharmacological interventions, compared to an inactive control intervention, on subjective fatigue in people with PD.We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library); MEDLINE (...) (via PubMed); Ovid EMBASE; EBSCO CINAHL; Ovid PsycINFO; PEDro; and the WHO International Clinical Trials Registry Platform Search Portal up to April 2015. References of included studies and identified review articles were screened for additional studies. There were no restrictions based on language, date of publication or study setting.Randomised controlled trials (RCTs) that report on subjective fatigue in people with PD.Two review authors independently performed study selection, data collection

Full Text available with Trip Pro

2015 Cochrane

115. Exercise therapy for fatigue in multiple sclerosis. (PubMed)

Exercise therapy for fatigue in multiple sclerosis. Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system affecting an estimated 1.3 million people worldwide. It is characterised by a variety of disabling symptoms of which excessive fatigue is the most frequent. Fatigue is often reported as the most invalidating symptom in people with MS. Various mechanisms directly and indirectly related to the disease and physical inactivity have been proposed to contribute (...) to the degree of fatigue. Exercise therapy can induce physiological and psychological changes that may counter these mechanisms and reduce fatigue in MS.To determine the effectiveness and safety of exercise therapy compared to a no-exercise control condition or another intervention on fatigue, measured with self-reported questionnaires, of people with MS.We searched the Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group Trials Specialised Register, which, among other sources

Full Text available with Trip Pro

2015 Cochrane

116. Interventions for post-stroke fatigue. (PubMed)

Interventions for post-stroke fatigue. Post-stroke fatigue (PSF) is a common and distressing problem after stroke. The best ways to prevent or treat PSF are uncertain. Several different interventions can be argued to have a rational basis.To determine whether, among people with stroke, any intervention reduces the proportion of people with fatigue, fatigue severity, or both; and to determine the effect of intervention on health-related quality of life, disability, dependency and death (...) for PSF.Two review authors independently extracted data and assessed risk of bias for each included trial. The primary outcomes were severity of fatigue, or proportion of people with fatigue after treatment. We performed separate analyses for trials investigating efficacy in treating PSF, trials investigating efficacy in preventing PSF and trials not primarily investigating efficacy in PSF but which reported fatigue as an outcome. We pooled results from trials that had a control arm. For trials

Full Text available with Trip Pro

2015 Cochrane

117. Canadian stroke best practice recommendations: mood, cognition and fatigue following stroke practice guidelines

Canadian stroke best practice recommendations: mood, cognition and fatigue following stroke practice guidelines Canadian Stroke Best Practice Recommendations: Mood, Cognition and Fatigue Following Stroke practice guidelines, update 2015 - Eskes - 2015 - International Journal of Stroke - Wiley Online Library The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

Full Text available with Trip Pro

2015 CPG Infobase

118. National Institutes of Health Pathways to Prevention Workshop: Advancing the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. (PubMed)

National Institutes of Health Pathways to Prevention Workshop: Advancing the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. The National Institutes of Health (NIH) Pathways to Prevention Workshop: Advancing the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome was cosponsored by the NIH Office of Disease Prevention and the Trans-NIH Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research Working Group. A multidisciplinary working group developed the agenda

Full Text available with Trip Pro

2015 Annals of Internal Medicine

119. Diagnostic Methods for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop. (PubMed)

Diagnostic Methods for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop. The diagnosis of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is based on clinical criteria, yet there has been no consensus regarding which set of criteria best identifies patients with the condition. The Institute of Medicine has recently proposed a new case definition and diagnostic algorithm.To review methods

Full Text available with Trip Pro

2015 Annals of Internal Medicine

120. Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop. (PubMed)

Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop. Myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is a debilitating multisystem condition affecting more than 1 million adults in the United States.To determine benefits and harms of treatments for adults with ME/CFS and identify future research needs.MEDLINE, PsycINFO, and Cochrane databases (January 1988 to September 2014 (...) case definitions of CFS, the immune modulator rintatolimod improved some measures of exercise performance compared with placebo in 2 trials (low strength of evidence). Trials of galantamine, hydrocortisone, IgG, valganciclovir, isoprinosine, fluoxetine, and various complementary medicines were inconclusive (insufficient evidence). Counseling therapies and graded exercise therapy compared with no treatment, relaxation, or support improved fatigue, function, global improvement, and work impairment

Full Text available with Trip Pro

2015 Annals of Internal Medicine